Graphical Abstract: Created in BioRender. Stockwell, C. 2025. https://BioRender.com/l62r123.

Ligon JA, Sayour EJ. Spotlighting cellular therapies to advance the treatment of medulloblastoma. Neuro Oncol. 2023;25:628–30. https://doi.org/10.1093/neuonc/noad005.

Article  PubMed  PubMed Central  Google Scholar 

Baroni LV, Sampor C, Gonzalez A, et al. Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen. Neuro Oncol. 2020;22:1873–81. https://doi.org/10.1093/neuonc/noaa122.

Article  PubMed  PubMed Central  Google Scholar 

Shaik S, Maegawa S, Gopalakrishnan V. Medulloblastoma: novel insights into emerging therapeutic targets. Expert Opin Ther Targets. 2021;25:615–9. https://doi.org/10.1080/14728222.2021.1982896.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Bree NFHN, Wilhelm M. The tumor microenvironment of medulloblastoma: an intricate multicellular network with therapeutic potential. Cancers (Basel). 2022;14. https://doi.org/10.3390/cancers14205009.

Castel D, Philippe C, Calmon R, et al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol. 2015;130:815–27. https://doi.org/10.1007/s00401-015-1478-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gállego Pérez-Larraya J, Garcia-Moure M, Labiano S, et al. Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma. N Engl J Med. 2022;386:2471–81. https://doi.org/10.1056/NEJMoa2202028.

Article  PubMed  Google Scholar 

Ehteda A, Khan A, Rajakumar G, et al. Microtubule-targeting combined with HDAC inhibition is a novel therapeutic strategy for diffuse intrinsic pontine gliomas. Mol Cancer Ther. 2023. https://doi.org/10.1158/1535-7163.MCT-23-0179.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Zhao C, Li S, et al. Immune microenvironment and immunotherapies for diffuse intrinsic pontine glioma. Cancers (Basel). 2023;15. https://doi.org/10.3390/cancers15030602.

O’Keeffe E, Campbell M. Modulating the paracellular pathway at the blood-brain barrier: current and future approaches for drug delivery to the CNS. Drug Discov Today Technol. 2016;20:35–9. https://doi.org/10.1016/j.ddtec.2016.07.008.

Article  PubMed  Google Scholar 

de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374–403. https://doi.org/10.1016/j.ccell.2023.02.016.

Article  CAS  PubMed  Google Scholar 

Ozkaya T, Chien F, Boya M, et al. Biom-62. circulating tumor cells in medulloblastoma: a novel peripheral biomarker for cns disease. Neuro Oncol. 2024;26:viii34–viii34. https://doi.org/10.1093/neuonc/noae165.0134.

Article  Google Scholar 

Stockwell, C. Figure 1: created in BioRender. 2025. https://www.BioRender.com/j13k353. Accessed 12 Mar 2025.

Ballester LY, Wang Z, Shandilya S, et al. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. Am J Surg Pathol. 2013;37:1357–64. https://doi.org/10.1097/PAS.0b013e318294e817.

Article  PubMed  PubMed Central  Google Scholar 

Liu G, Qiu Y, Zhang P, et al. Immunogenic cell death enhances immunotherapy of diffuse intrinsic pontine glioma: from preclinical to clinical studies. Pharmaceutics. 2022;14. https://doi.org/10.3390/pharmaceutics14091762.

Arrillaga-Romany I, Lassman A, McGovern SL, et al. ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma. Neuro Oncol. 2024;26:S173–81. https://doi.org/10.1093/neuonc/noae031.

Article  PubMed  PubMed Central  Google Scholar 

Venneti S, Kawakibi AR, Ji S, et al. Clinical Efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways. Cancer Discov. 2023;13:2370–93. https://doi.org/10.1158/2159-8290.CD-23-0131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bailey CP, Wang R, Figueroa M, et al. Computational immune infiltration analysis of pediatric high-grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location. Comp Sys Onco. 2021;1. https://doi.org/10.1002/cso2.1016.

Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131:803–20. https://doi.org/10.1007/s00401-016-1545-1.

Article  PubMed  Google Scholar 

Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23:1231–51. https://doi.org/10.1093/neuonc/noab106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Larson JD, Kasper LH, Paugh BS, et al. Histone H3.3 K27M accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression. Cancer Cell. 2019;35:140-155.e7. https://doi.org/10.1016/j.ccell.2018.11.015.

Article  CAS  PubMed  Google Scholar 

Jain SU, Do TJ, Lund PJ, et al. PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism. Nat Commun. 2019;10:2146. https://doi.org/10.1038/s41467-019-09981-6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lewis PW, Müller MM, Koletsky MS, et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science. 2013;340:857–61. https://doi.org/10.1126/science.1232245.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hervás-Corpión I, Gallardo-Orihuela A, Catalina-Fernández I, et al. Potential diagnostic value of the differential expression of histone H3 variants between low- and high-grade gliomas. Cancers (Basel). 2021;13. https://doi.org/10.3390/cancers13215261.

Zhu X, Lazow MA, Schafer A, et al. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathol Commun. 2021;9:14. https://doi.org/10.1186/s40478-020-01107-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ross JL, Puigdelloses-Vallcorba M, Piñero G, et al. Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations. Immunity. 2024;57:2669-2687.e6. https://doi.org/10.1016/j.immuni.2024.09.007.

Article  CAS  PubMed  Google Scholar 

Andrade AF, Annett A, Karimi E, et al. Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function. Nat Commun. 2024;15:7769. https://doi.org/10.1038/s41467-024-52096-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin GL, Nagaraja S, Filbin MG, et al. Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma. Acta Neuropathol Commun. 2018;6:51. https://doi.org/10.1186/s40478-018-0553-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ross JL, Velazquez Vega J, Plant A, et al. Tumour immune landscape of paediatric high-grade gliomas. Brain. 2021;144:2594–609. https://doi.org/10.1093/brain/awab155.

Article  PubMed  PubMed Central  Google Scholar 

Liu I, Jiang L, Samuelsson ER, et al. The landscape of tumor cell states and spatial organization in H3–K27M mutant diffuse midline glioma across age and location. Nat Genet. 2022;54:1881–94. https://doi.org/10.1038/s41588-022-01236-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robinson MH, Vasquez J, Kaushal A, et al. Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma. J Immunother Cancer. 2020;8. https://doi.org/10.1136/jitc-2020-001066.

Plant AS, Koyama S, Sinai C, et al. Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response. J Neurooncol. 2018;137:269–78. https://doi.org/10.1007/s11060-017-2737-9.

Article  PubMed  Google Scholar 

Lee C, Lee J, Choi SA, et al. M1 macrophage recruitment correlates with worse outcome in SHH medulloblastomas. BMC Cancer. 2018;18:535. https://doi.org/10.1186/s12885-018-4457-8.

Article  CAS  PubMed  PubMed Central  Google Scholar